BioSpace News Archive

Job Trends

Healthcare Learning Innovations Launches May Webinar Wednesday Series

Virtual clinical simulations and scenarios help nursing programs address industry issues while improving learning outcomes

May 14, 2019
·
2 min read
Policy

Lipocine Announces TLANDO™ NDA PDUFA Action Date of November 9, 2019

Lipocine Inc. announced that the U.S. Food and Drug Administration has accepted its New Drug Application for TLANDO as testosterone replacement therapy in adult males for conditions associated with a deficiency of endogenous testosterone, also known as hypogonadism.

May 14, 2019
·
3 min read
Biotech Beach

Surgical Implant Maker Xenco Medical Deploys First Interactive Vending Machines Designed for Spine Surgery Instruments and Implants

Surgical implant maker Xenco Medical has announced the launch of the first interactive vending machines designed for spine surgery instruments and implants.

May 14, 2019
·
3 min read
Biotech Beach

NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting

NuVasive, Inc. announced the Company continues its commitment to the Society of Lateral Access Surgery as a Global Partner, the leading sponsorship level in the partnership program, at the 12th annual SOLAS meeting being held May 16-18, 2019 in Miami, Florida.

May 14, 2019
·
4 min read
Policy

Mesothelioma Victims Center Now Urges a Navy Veteran with Mesothelioma or Asbestos Exposure Lung Cancer to Not Put Off the Compensation Process - Call Them for Direct Access to Attorney Erik Karst and His Team at Karst von Oistea

The Mesothelioma Victims Center says, “We are urging a Navy Veteran who has just been diagnosed with mesothelioma or asbestos exposure lung cancer to not put off starting the financial compensation process.

May 14, 2019
·
3 min read
Debiopharm Awarded $2.1 Million From CARB-X in the Fight Against a Highly Resistant Nosocomial-Pneumonia Causing Superbug

The grant will support development of the Debio 1454 program to treat hospital-acquired pneumonia (HAP) caused by Acinetobacter baumannii

May 14, 2019
·
2 min read
Biotech Beach

Simulations Plus to Present at B. Riley FBR Investor Conference on May 22, 2019

Simulations Plus, Inc. announced that Shawn O’Connor, chief executive officer, will present at the 20th Annual B. Riley FBR Institutional Investor Conference on Wednesday, May 22, at 10:30 a.m. (PDT) in Room 8.

May 14, 2019
·
1 min read
Drug Development

Oral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates Superior Dose-Related Target Engagement Activity to PTG-100 in Single Ascending Dose Phase 1 Study

Protagonist Therapeutics, Inc. announced results from the initial single ascending dose (SAD) part of the Phase 1 study of PN-943, an oral, gut-restricted alpha-4-beta-7 integrin specific antagonist in development for the potential treatment of inflammatory bowel disease (IBD).

May 14, 2019
·
6 min read
Deals

Rare Strength Powers Growth - Sobi Capital Markets Day 2019

Swedish Orphan Biovitrum AB is hosting a Capital Markets Day at Karolinska Institutet Biomedicum in Solna, Sweden

May 14, 2019
·
3 min read
Genetown

Acceleron to Present at the UBS Global Healthcare Conference

Acceleron Pharma Inc. announced that members of the management team will present at the UBS Global Healthcare Conference on Monday, May 20th, 2019 at 11:00 a.m. EDT in New York, NY.

May 14, 2019
·
1 min read